Plasma Cell Neoplasm — Trials

Plasma Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 3,401–3,420 of 3,420 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00358020	Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients	completed	Phase 2	30	University of Turin, ItalyOTHER	1	Dec 4, 2006	clinicaltrials
NCT00396045	Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma	completed	Phase 1 / Phase 2	54	University of Turin, ItalyOTHER	1	Nov 30, 2006	clinicaltrials